The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,098.00
Bid: 9,110.00
Ask: 9,114.00
Change: 120.00 (1.34%)
Spread: 4.00 (0.044%)
Open: 9,066.00
High: 9,144.00
Low: 9,008.00
Prev. Close: 8,978.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unscheduled Trading Update

19 Jun 2023 12:53

RNS Number : 1892D
Next PLC
19 June 2023
 

 

 

Date:

Embargoed until 12:00 hrs, Monday 19 June 2023

 

Contacts:

Amanda James, Group Finance Director (analyst calls)

Tel: 0333 777 8888

 

Alistair Mackinnon-Musson, Rowbell PR

Tel: 020 7717 5239

UNSCHEDULED TRADING UPDATE - 19 JUNE 2023

HEADLINES

·

Trading in the last seven weeks has been materially better than the guidance we issued in May and we are updating the market accordingly.

·

Full price sales1 in the first seven weeks of the second quarter were up +9.3% versus last year. This compares to our guidance of -5%. In the period, we have beaten our full price sales estimates by £93m.

·

We are upgrading our full price sales guidance for the full year by £137m and our full year profit guidance by £40m to £835m.

1. Full price sales are VAT exclusive sales (including the value of commission based sales), less items sold in Sale events and Clearance. They do not include sales from Joules and Total Platform. Full price sales are not statutory sales.

REASONS FOR IMPROVED PERFORMANCE

We believe the reasons for the over-performance are as follows:

1. The change in weather. The onset of warmer weather has made a significant difference to our performance, particularly coming after a wet and cold April.

2. In an inflationary environment, annual salary increases deliver a significant uplift in real household income at the time they are awarded. For example, during April annual inflation2 was running at 8.7% and monthly inflation was 1.2%; if an individual received a pay rise of 5.0%, then their real income would have risen by 3.8% in that month. We do not think it is a coincidence that sales stepped forward so markedly at a time of year when many organisations make their annual pay awards.

2. Source: Office of National Statistics, Consumer Prices Index (CPI) published 24 May 2023.

OUTLOOK FOR THE REST OF THE YEAR

If recent pay rises and the sudden change in weather have indeed contributed to the current over-performance, then it is reasonable to expect that the effect will diminish over time because ongoing inflation will slowly erode the positive effect of annual pay increases. This is why we are not anticipating the current performance to continue at the same level going forward, albeit we have moderately improved our guidance for the rest of the year (see guidance below).

GUIDANCE FOR FULL PRICE SALES AND PROFIT BEFORE TAX

Our new guidance is set out in the tables below, alongside the previous guidance we gave in our Q1 Trading Statement on 4 May 2023.

Revised full price sales guidance for the rest of the year and full year

Full price sales versus last year

Actuals and new guidance

versus last year

Previous guidance

versus last year

Q1 (actual for reference)

- 0.7%

- 0.7%

Q2 actuals to date (7 weeks)

+9.3%

- 5.0%

Year to date (actuals)

+3.0%

- 2.4%3

Rest of year guidance

+0.5%

- 1.1%4

Full year guidance

+1.4%

- 1.5%

3. Previous guidance of -2.4% is the combination of Q1 actuals of -0.7% and Q2 guidance of -5%, as given in our Q1 Trading Statement.

4. Previous guidance of -1.1% is the combination of Q2 guidance of -5% and H2 guidance of -0.2%, as given in our Q1 Trading Statement.

Revised sales and profit guidance for the full year

This revised guidance increases our full price sales for the full year by £137m (of which £93m has already been achieved). Profit before tax for the full year is now expected to be £835m, which is £40m higher than our previous guidance. 

Full year guidance

New guidance

Versus

last year

Previous guidance

Versus

last year

Full price sales

£4.67bn

+1.4%

£4.53bn

- 1.5%

NEXT Profit before tax

£835m

- 4.1%

£795m

- 8.7%

SECOND QUARTER TRADING STATEMENT

Our next sales update will cover the first 26 weeks of the year to 29 July 2023 and is scheduled for Thursday 3 August 2023. 

 

Regulatory Information

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

 

This announcement contains Inside Information as defined in Article 7 of the Market Abuse Regulation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFELRLIALIV
Date   Source Headline
1st May 20249:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTrading Statement
29th Apr 20244:30 pmRNSDirector/PCA Shareholding
26th Apr 20246:12 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:31 pmRNSHolding(s) in Company
12th Apr 20242:16 pmRNSAnnual Financial Report
8th Apr 20244:43 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20249:50 amRNSHolding(s) in Company
22nd Mar 20242:26 pmRNSDirector/PDMR Shareholding
22nd Mar 20242:24 pmRNSDirector/PDMR Shareholding
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.